The Enterprise Value as of November 2024 (TTM) for SAB Biotherapeutics, Inc. (SABS) is 24.24M

According to SAB Biotherapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 24.24M. This represents a change of 67.82% compared to the average of 14.44M of the last 4 quarters.

SAB Biotherapeutics, Inc. (SABS) Historical Enterprise Value (quarterly & annually)

How has SABS Enterprise Value performed in the past?

The mean historical Enterprise Value of SAB Biotherapeutics, Inc. over the last ten years is 971.63M. The current 24.24M Enterprise Value has changed 149.44% with respect to the historical average. Over the past ten years (40 quarters), SABS's Enterprise Value was at its highest in in the September 2021 quarter at 437.56M. The Enterprise Value was at its lowest in in the December 2023 quarter at -9882010.68.

SAB Biotherapeutics, Inc. (SABS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of SAB Biotherapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

SAB Biotherapeutics, Inc. (SABS) Average Enterprise Value

How has SABS Enterprise Value performed in the past?

The current Enterprise Value of SAB Biotherapeutics, Inc. (SABS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

SAB Biotherapeutics, Inc. (SABS) Enterprise Value vs. Peers

How is SABS’s Enterprise Value compared to its peers?

SAB Biotherapeutics, Inc.’s Enterprise Value is less than Comera Life Sciences Holdings, Inc. (0), greater than Processa Pharmaceuticals, Inc. (-1587053.00), greater than Fresh Tracks Therapeutics, Inc. (15.28K), greater than Third Harmonic Bio, Inc. (-6567217.00), less than Cingulate Inc. (269.19M), greater than Anebulo Pharmaceuticals, Inc. (5.36M), less than Cadrenal Therapeutics, Inc. Common Stock (36.46M), greater than Monopar Therapeutics Inc. (20.50M), less than Unicycive Therapeutics, Inc. (100.06M), greater than Quoin Pharmaceuticals, Ltd. (23.47M), greater than Cardio Diagnostics Holdings, Inc. (-162664.00), greater than Virax Biolabs Group Limited (9.47M), greater than PaxMedica, Inc. Common Stock (5.36M), greater than null (757.99K),

Build a custom stock screener for SAB Biotherapeutics, Inc. (SABS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like SAB Biotherapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

SAB Biotherapeutics, Inc. (SABS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like SAB Biotherapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.